Moxifloxacin
Moxifloxacin (Avelox) is a broad-spectrum, fourth-generation fluoroquinolone antibiotic effective against Gram-positive, Gram-negative, atypical pathogens, and multi-drug resistant Streptococcus pneumoniae. It is widely used in research for in vitro susceptibility testing and in vivo models of respiratory and systemic bacterial infections.
Product Specifications
CAS Number
151096-09-2
Product Name Alternative
Moxeza, Moxifloxacin, inhibit, Inhibitor, Antibiotic, Avelox, Bacterial
Field of Research
Infectious Disease & Virology, Pharmacology & Drug Discovery
Purity
99.76% (May vary between batches)
Solubility
DMSO:19.23 mg/mL (47.9 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:3.3 mg/mL (8.22 mM)
Smiles
O (C) C1=C2N (C=C (C (O) =O) C (=O) C2=CC (F) =C1N3C[C@]4 ([C@@] (C3) (NCCC4) [H]) [H]) C5CC5
Molecular Formula
C21H24FN3O4
Molecular Weight
401.43
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Timmdc1 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC)
Recombinant Bacillus subtilis 3-dehydroquinate dehydratase (aroC)